Semaglutide Tablet — FDA Drug Shortage

To Be Discontinued — Novo Nordisk, Inc.

The FDA lists a drug shortage record for Semaglutide Tablet (tablet) from Novo Nordisk, Inc. with status To Be Discontinued. The shortage was first posted on Jun 4, 2026.

Shortage details

Status
To Be Discontinued
Company
Novo Nordisk, Inc.
Package NDC
0169-4307-30
Dosage Form
Tablet
Presentation
Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)
Initial Posting
Jun 4, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.